During the past decade, Hospital Nuestra Senora de la Misericordia conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 5 clinical trials were completed, i.e. on average, 166.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Nuestra Senora de la Misericordia" #1 sponsor was "Janssen Research & Development, LLC" with 2 trials, followed by "Astellas Pharma Inc" with 1 trials sponsored, "Cubist Pharmaceuticals LLC" with 1 trials sponsored, "Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Nuestra Senora de la Misericordia" #1 collaborator was "ARTTIC International Management Services" with 1 trials as a collaborator, "Basilea Pharmaceutica International Ltd" with 1 trials as a collaborator, "Federación Argentina de Cardiología FAC" with 1 trials as a collaborator, "Ferrer Internacional S.A." with 1 trials as a collaborator and "Fundacion Clinic per a la Recerca Biomédica" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Nuestra Senora de la Misericordia" are "Influenza A" (2 trials), "Aspergillosis" (1 trials), "Clostridium Difficile Infection" (1 trials), "Complicated Intra-abdominal Infection" (1 trials) and "Invasive Fungal Infections" (1 trials). Many other conditions were trialed in "Hospital Nuestra Senora de la Misericordia" in a lesser frequency.

Most popular intervention types in "Hospital Nuestra Senora de la Misericordia" are "Drug" (5 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Pimodivir 600 mg" (2 trials), "SOC Treatment" (2 trials), "CXA-101/ tazobactam and metronidazole" (1 trials) and "Clostridium difficile vaccine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Nuestra Senora de la Misericordia" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Nuestra Senora de la Misericordia". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Hospital Nuestra Senora de la Misericordia, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Nuestra Senora de la Misericordia, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".